stockrowMesoblast Limited (MESO) vs Vir Biotechnology, Inc. (VIR)
- Mesoblast Limited MESO 14.23 +0.92%
- Vir Biotechnology, Inc. VIR 12.19 +10.62%
Mesoblast Limited and Vir Biotechnology, Inc. are both Biotechnology companies. Mesoblast Limited and Vir Biotechnology, Inc. are of similar size ($1.9B and $1.8B). Vir Biotechnology, Inc. grew revenue faster over the last twelve months: 1,696.0% against −26.5%. Vir Biotechnology, Inc. has the higher net margin (−61.0% vs −1,091.7%) and the lower return on invested capital (−30.3% vs 0.00%). Across the 18 metrics below, Mesoblast Limited leads on 9 and Vir Biotechnology, Inc. on 9.
Valuation
Profitability
| Metric | MESO | VIR | Biotechnology median |
|---|---|---|---|
| Gross margin | (269.72%) | 99.99% | 68.51% |
| Operating margin | (826.28%) | (69.82%) | 0.00% |
| Net margin | (1,091.71%) | (61.03%) | 0.00% |
| Free cash flow margin | 0.00% | (46.87%) | 0.00% |
| Return on equity | 0.00% | (21.84%) | (51.96%) |
| Return on assets | 0.00% | (17.34%) | (46.06%) |
| Return on invested capital | 0.00% | (30.32%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack